James Harrison, MD
Otolaryngology · Mobile, ALNPI 1326042987
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,518 of the $3,050 with a category attached, or 82.5%. 20 manufacturers reported payments, led by Aerin Medical Inc. at 27.1% of the total.
Across 95 payments — averaging $32.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerin Medical Inc.$826
- Optinose US, Inc.$496
- Sanofi$375
- Medtronic$334
- Regeneron Healthcare Solutions, Inc.$238
- Stryker$136
- plus $645 from 14 others
What the payments were for
- Consulting fees$40013%
- Food & beverage$2,51883%
- Education$1324%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerin Medical Inc. | 9 | $826 |
| Optinose US, Inc. | 22 | $496 |
| Sanofi | 15 | $375 |
| Medtronic | 9 | $334 |
| Regeneron Healthcare Solutions, Inc. | 8 | $238 |
| Stryker | 2 | $136 |
| Novartis | 5 | $110 |
| Novo Nordisk | 7 | $104 |
| Acclarent, Inc | 1 | $78 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $52 |
| Sight Sciences, Inc. | 1 | $47 |
| Phathom Pharmaceuticals, Inc. | 3 | $47 |
| Merck | 2 | $37 |
| Amgen | 1 | $34 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $30 |
| GSK | 2 | $29 |
| AstraZeneca | 1 | $22 |
| Eyevance Pharmaceuticals LLC | 1 | $21 |
| AbbVie | 1 | $21 |
| Biohaven Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VivAer$400
- RhinAer$400
- Vivaer RF Stylus$236
- STEALTHSTATION S8 PLATFORM$128
- Xhance$119
How this compares
$3,050 in reported general payments places this provider in the 70th percentile of 155 otolaryngology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 358 | $10,847 |
| Fluticasone Propionate | 437 | $8,294 |
| Epinephrine | 40 | $7,700 |
| Pantoprazole Sodium | 454 | $3,744 |
| Famotidine | 510 | $3,607 |
| Qvar RedihalerBeclomethasone Dipropionate | 12 | $3,284 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 131 | $1,713 |
| Montelukast Sodium | 190 | $1,620 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 37 | $1,323 |
| Ipratropium Bromide | 29 | $956 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 112 | $580 |
| Doxycycline Monohydrate | 36 | $452 |
| Methylprednisolone | 53 | $432 |
| Nystatin | 11 | $432 |
| Levocetirizine Dihydrochloride | 55 | $396 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Mobile
- Andrea McMurphyMobile$8K
- Douglas HolmesMobile$3K
- Kacie OglesbyMobile$3K
- Mark GacekMobile$3K
- Alfred NeumannMobile$3K
- Christopher WeeksMobile$3K
- John DavisHoover$251K
- William McFeelyHuntsville$70K
- Michael SillersBirmingham$53K
- Justin TurnerBirmingham$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.